Thousand Oaks, California, September 3, 2025
News Summary
Amgen is investing $600 million in a new research and development center in Thousand Oaks, California. This facility will focus on next-generation drug discovery and aims to enhance collaboration among scientists and engineers. Amidst rising pressures on supply chains and the pharmaceutical sector, Amgen’s commitment aligns with a broader industry trend of reshoring production to the U.S. The investment emphasizes the importance of domestic scientific research and innovation.
California
Amgen is set to invest $600 million in a new research and development center located in Thousand Oaks, California, which is expected to break ground in the third quarter of this year. This facility aims to consolidate the company’s researchers, engineers, and scientists under one roof, focusing on advancing next-generation drug discovery. Unlike Amgen’s manufacturing sites, this new center will primarily serve as a hub for collaboration and innovative scientific tools rather than producing drugs.
The investment comes amid ongoing challenges related to U.S. import tariffs and supply chain pressures, highlighting Amgen’s commitment to increasing domestic research and production capacities. These advancements are crucial as the entire biomanufacturing sector in the U.S. is witnessing a significant surge, with over $270 billion in U.S. projects announced by 15 major drugmakers for 2025 alone, representing a staggering 185% increase in biomanufacturing demand, according to data from the commercial real estate firm JLL.
Additionally, Alexandria Real Estate Equities has reported a considerable uptick in lab space, adding more than half a million square feet in the first half of this year. This increase is part of a broader response to the rising demand for pharmaceutical research and development space in the country. Already, Amgen has made substantial investments in other manufacturing facilities, including a $900 million expansion in Columbus, Ohio, and a $1 billion investment for a new site in Holly Springs, North Carolina.
The U.S. Food and Drug Administration (FDA) has also taken steps to improve the industry’s infrastructure by introducing programs to streamline the approval process for new drug manufacturing sites. Complementing these efforts, the White House is focused on reducing construction timelines for pharmaceutical facilities, which commonly take up to ten years to complete.
Amgen attributes a portion of these domestic investments to the Tax Cuts and Jobs Act of 2017 and is optimistic about future legislation that could enhance the industry’s growth. The company’s CEO has stated that this investment is primarily aimed at fortifying the U.S. drug supply chains and boosting domestic scientific research and innovation.
Furthermore, Amgen’s expansion aligns with a trend where other leading pharmaceutical companies, including AstraZeneca, Eli Lilly, Sanofi, and Novartis, have announced significant investments in U.S. facilities recently. This trend supports policies aimed at reshoring pharmaceutical production back to American soil, addressing concerns about the healthcare sector’s dependency on foreign sources.
Key Highlights of Amgen’s Investment
- Investment Amount: $600 million
- Location: Thousand Oaks, California
- Priority: Research and development for drug discovery
- Manufacturing: Not a manufacturing facility
- Industry Growth: 185% increase in biomanufacturing demand by 2025
- Supporting Policies: Streamlined approval process and reduced construction timelines
Conclusion
As Amgen continues to push forward with its substantial investment and collaborative efforts in California, the pharmaceutical landscape in the U.S. is set to transform, reinforcing the importance of domestic production capacities and innovation in a rapidly evolving industry.
FAQs
What is the focus of Amgen’s new facility in Thousand Oaks?
The new facility will focus on research and development for next-generation drug discovery, consolidating Amgen’s researchers, engineers, and scientists in one location.
What is the total investment amount for the new R&D center?
Amgen plans to invest $600 million in the new research and development center.
When is construction expected to begin?
Construction is expected to begin in the third quarter of this year.
Is the new facility going to be a drug manufacturing site?
No, the new center will not be a drug manufacturing facility; it will focus on enhancing collaboration among researchers and providing advanced tools for scientific discovery.
Investment Chart
| Investment | Amount | Location | Focus |
|---|---|---|---|
| Amgen R&D Center | $600 million | Thousand Oaks, California | Research & Development |
| Columbus Manufacturing Expansion | $900 million | Columbus, Ohio | Manufacturing |
| Holly Springs Manufacturing Site | $1 billion | Holly Springs, North Carolina | Manufacturing |
Deeper Dive: News & Info About This Topic
- Fierce Biotech: Amgen to Build $600M R&D Site
- Wikipedia: Amgen
- CoStar: Amgen Extends Pharmaceutical Real Estate Push
- Google Search: Amgen biotech investments
- Reuters: Amgen to Expand Ohio Biotech Manufacturing Plant
Author: STAFF HERE HUNTINGTON BEACH
The Huntington Beach Staff Writer represents the experienced team at HEREHuntingtonBeach.com, your go-to source for actionable local news and information in Huntington Beach, Orange County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the Huntington Beach Surf City USA Marathon, the U.S. Open of Surfing, Fourth of July celebrations at the Huntington Beach Pier, and community festivals at Huntington Beach Central Park. Our coverage extends to key organizations like the Huntington Beach Chamber of Commerce and Visit Huntington Beach, plus leading businesses in retail, hospitality, and outdoor recreation that drive the local economy. As part of the broader HERE network, including HEREAnaheim.com, HERECostaMesa.com, HERESantaAna.com, and HERELosAngeles.com, we provide comprehensive, credible insights into Southern California's dynamic landscape.
